A detailed history of Point72 Europe (London) LLP transactions in Pfizer Inc stock. As of the latest transaction made, Point72 Europe (London) LLP holds 132,158 shares of PFE stock, worth $3.53 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
132,158
Holding current value
$3.53 Million
% of portfolio
0.34%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $3.34 Million - $3.91 Million
132,158 New
132,158 $3.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Point72 Europe (London) LLP Portfolio

Follow Point72 Europe (London) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Europe (London) LLP with notifications on news.